As of 2022, an estimated 50 million people globally were infected with chronic hepatitis C virus (HCV), with an estimated 1 ...

A cross-sectional analysis shows that long-acting antiretroviral therapy sustains viral suppression regardless of initial ...

Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics.